Yumiko Maruyama

1.6k total citations
80 papers, 1.1k citations indexed

About

Yumiko Maruyama is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yumiko Maruyama has authored 80 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 18 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yumiko Maruyama's work include Hematopoietic Stem Cell Transplantation (26 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Yumiko Maruyama is often cited by papers focused on Hematopoietic Stem Cell Transplantation (26 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Yumiko Maruyama collaborates with scholars based in Japan, United States and South Korea. Yumiko Maruyama's co-authors include Yasuhisa Shinomura, Yasushi Adachi, Hiroyuki Yamamoto, Masanori Ii, Mitsuru Furukawa, Tomokazu Yoshizaki, Hiroshi Sato, Shigeyuki Murono, Hiroshi Sato and Chang‐Soo Park and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Yumiko Maruyama

67 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yumiko Maruyama Japan 13 376 363 355 186 142 80 1.1k
Anna E. Kossakowska Canada 13 384 1.0× 237 0.7× 276 0.8× 172 0.9× 184 1.3× 22 1.1k
Pascale Reverdiau France 21 236 0.6× 257 0.7× 420 1.2× 372 2.0× 135 1.0× 40 1.1k
T. E. Cawston United Kingdom 18 374 1.0× 670 1.8× 317 0.9× 223 1.2× 166 1.2× 28 1.6k
Takahiko Aoyagi Japan 23 284 0.8× 266 0.7× 541 1.5× 126 0.7× 53 0.4× 50 1.3k
Ariel M. Rubinstein Israel 16 174 0.5× 155 0.4× 629 1.8× 94 0.5× 123 0.9× 33 1.3k
Camille Ettelaie United Kingdom 21 154 0.4× 181 0.5× 488 1.4× 464 2.5× 130 0.9× 68 1.4k
Birgitte Walgreen Netherlands 18 257 0.7× 149 0.4× 405 1.1× 80 0.4× 81 0.6× 52 1.4k
Gerhard Dekan Austria 20 325 0.9× 126 0.3× 376 1.1× 89 0.5× 314 2.2× 54 1.2k
Yoichiro Moriya Japan 22 693 1.8× 157 0.4× 364 1.0× 102 0.5× 258 1.8× 49 1.6k
Ladislav Burýšek Czechia 15 406 1.1× 187 0.5× 292 0.8× 194 1.0× 54 0.4× 18 1.3k

Countries citing papers authored by Yumiko Maruyama

Since Specialization
Citations

This map shows the geographic impact of Yumiko Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumiko Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumiko Maruyama more than expected).

Fields of papers citing papers by Yumiko Maruyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumiko Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumiko Maruyama. The network helps show where Yumiko Maruyama may publish in the future.

Co-authorship network of co-authors of Yumiko Maruyama

This figure shows the co-authorship network connecting the top 25 collaborators of Yumiko Maruyama. A scholar is included among the top collaborators of Yumiko Maruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumiko Maruyama. Yumiko Maruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakamoto, Tatsuhiro, Hirayasu Kai, Toshiaki Usui, et al.. (2025). Multiple Myeloma in a Patient with Birt-Hogg-Dubé Syndrome. Internal Medicine. 64(18). 2764–2768. 1 indexed citations
2.
Iwasaki, Makoto, Masahiro Hirayama, Koji Kawamura, et al.. (2025). Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation. Leukemia. 39(4). 951–961. 1 indexed citations
3.
Jo, Tomoyasu, Yu Akahoshi, Tadakazu Kondo, et al.. (2024). First complete remission favours haploidentical haematopoietic stem cell transplantation with post‐transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia. British Journal of Haematology. 204(5). 1913–1919. 2 indexed citations
4.
Arai, Yasuyuki, Tadakazu Kondo, Shohei Mizuno, et al.. (2024). Prognostic factors in haploidentical transplantation with post-transplant cyclophosphamide for acute myeloid leukemia. Cytotherapy. 26(6). 592–598. 2 indexed citations
5.
Maruyama, Yumiko. (2024). Abscess Tonsillectomy for the Treatment of Severe Peritonsillar Abscess. Practica Oto-Rhino-Laryngologica. 117(5). 482–483.
6.
7.
8.
Tani, Hideki, Hiroyasu Kaya, Yumiko Maruyama, et al.. (2023). Neutralizing Antibody Levels and Epidemiological Characteristics of Patients with Breakthrough COVID-19 Infection in Toyama, Japan. Japanese Journal of Infectious Diseases. 76(5). 319–322. 1 indexed citations
9.
Koh, Hideo, Takaaki Konuma, Yoshimitsu Shimomura, et al.. (2023). HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome. Transplantation and Cellular Therapy. 30(3). 316.e1–316.e12. 1 indexed citations
10.
Fuji, Shigeo, Junichi Sugita, Yuho Najima, et al.. (2023). Low‐ versus standard‐dose post‐transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation. British Journal of Haematology. 204(3). 959–966. 6 indexed citations
11.
Shimomura, Yoshimitsu, Sho Komukai, Tetsuhisa Kitamura, et al.. (2023). Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide. Bone Marrow Transplantation. 59(1). 66–75. 2 indexed citations
12.
Tamaki, Masaharu, Yu Akahoshi, Yosuke Okada, et al.. (2023). Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients. Cytotherapy. 25(11). 1220–1228. 1 indexed citations
13.
14.
Sugita, Junichi, Yoshiko Atsuta, Hirohisa Nakamae, et al.. (2022). Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation. Bone Marrow Transplantation. 57(11). 1681–1688. 10 indexed citations
15.
Kurosawa, Shuhei, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.. (2021). Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis. Bone Marrow Transplantation. 56(12). 3008–3015. 5 indexed citations
16.
Tsukada, Yayoi & Yumiko Maruyama. (2019). A Case of Ramsay Hunt Syndrome with Multiple Cranial Nerve Neuropathy. Practica Oto-Rhino-Laryngologica. 112(10). 657–661.
17.
Nojima, Masanori, Reo Maruyama, Hiroshi Yasui, et al.. (2009). Genomic Screening for Genes Silenced by DNA Methylation Revealed an Association between RASD1 Inactivation and Dexamethasone Resistance in Multiple Myeloma. Clinical Cancer Research. 15(13). 4356–4364. 53 indexed citations
18.
Maruyama, Reo, Fumio Aoki, Minoru Toyota, et al.. (2006). Comparative Genome Analysis Identifies the Vitamin D Receptor Gene as a Direct Target of p53-Mediated Transcriptional Activation. Cancer Research. 66(9). 4574–4583. 86 indexed citations
19.
Maruyama, Yumiko, Kazuhira Endo, Toshiaki Tsukatani, & Mitsuru Furukawa. (2004). A Case of Neck Gas Gangrene with Iodoform Poisoning. Practica Oto-Rhino-Laryngologica. 97(7). 637–642.
20.
Maruyama, Yumiko & Mitsuru Furukawa. (2002). Seven Cases of Laryngospasms in Everyday Life.. Practica Oto-Rhino-Laryngologica. 95(5). 513–520.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna E. Kossakowska Breakdown of academic impact, for papers by Pascale Reverdiau Breakdown of academic impact, for papers by T. E. Cawston Breakdown of academic impact, for papers by Takahiko Aoyagi Breakdown of academic impact, for papers by Ariel M. Rubinstein Breakdown of academic impact, for papers by Camille Ettelaie Breakdown of academic impact, for papers by Birgitte Walgreen Breakdown of academic impact, for papers by Gerhard Dekan Breakdown of academic impact, for papers by Yoichiro Moriya Breakdown of academic impact, for papers by Ladislav Burýšek
Rankless by CCL
2026